Related Experiment Video
Updated: Jun 2, 2026

Collection of Serum- and Feeder-free Mouse Embryonic Stem Cell-conditioned Medium for a Cell-free Approach
Published on: January 8, 2017
The promise of human embryonic stem cells in aging-associated diseases
Odessa Yabut1, Harold S Bernstein
1Cardiovascular Research Institute, San Francisco, CA 94143, USA.
Abstract:
Aging-associated diseases are often caused by progressive loss or dysfunction of cells that ultimately affect the overall function of tissues and organs. Successful treatment of these diseases could benefit from cell-based therapy that would regenerate lost cells or otherwise restore tissue function. Human embryonic stem cells (hESCs) promise to be an important therapeutic candidate in treating aging-associated diseases due to their unique capacity for self-renewal and pluripotency. To date, there are numerous hESC lines that have been developed and characterized. We will discuss how hESC lines are derived, their molecular and cellular properties, and how their ability to differentiate into all three embryonic germ layers is determined. We will also outline the methods currently employed to direct their differentiation into populations of tissue-specific, functional cells. Finally, we will highlight the general challenges that must be overcome and the strategies being developed to generate highly-purified hESC-derived cell populations that can safely be used for clinical applications.
Insights
Human embryonic stem cells (hESCs) offer potential for treating aging diseases by regenerating cells. This review covers hESC derivation, properties, differentiation, and clinical application challenges.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Aging research
Background:
- Aging diseases stem from cellular loss/dysfunction, impacting organ function.
- Cell-based therapies can restore tissue function and regenerate cells.
- Human embryonic stem cells (hESCs) are promising for treating age-related diseases due to self-renewal and pluripotency.
Purpose of the Study:
- To review hESC derivation and characterization.
- To discuss factors determining hESC differentiation potential.
- To outline methods for directing hESC differentiation into specific cell types for clinical use.
Main Methods:
- Review of hESC derivation techniques.
- Analysis of molecular and cellular properties of hESCs.
- Examination of differentiation protocols for hESCs.
- Discussion of challenges in clinical translation.
Main Results:
- Numerous hESC lines are available and characterized.
- Understanding of hESC differentiation into three germ layers is advancing.
- Methods exist to direct hESC differentiation into tissue-specific cells.
Conclusions:
- hESCs hold significant therapeutic potential for aging-associated diseases.
- Further research is needed to overcome challenges in generating clinical-grade hESC-derived cells.
- Safe and effective clinical applications of hESC-based therapies are a key future goal.
More Related Videos
06:24Comparison of Two Representative Methods for Differentiation of Human Induced Pluripotent Stem Cells into Mesenchymal Stromal Cells
Published on: October 20, 2023
09:19High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
Published on: January 4, 2015
Related Concept Videos
Embryonic Stem Cells
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Embryonic Stem Cells
iPS Cell Differentiation
Stem Cell Culture
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Induced Pluripotent Stem Cells
Somatic cells are...